Compare, Analyse CORAL LAB. with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CORAL LAB. vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CORAL LAB.   TEVA PHARMA
EQUITY SHARE DATA
    CORAL LAB.
Mar-21
TEVA PHARMA
Dec-13
CORAL LAB./
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs4433,103-   
Low Rs952,695-   
Sales per share (Unadj.) Rs270.51,780.6-  
Earnings per share (Unadj.) Rs38.0111.2-  
Cash flow per share (Unadj.) Rs43.5255.2-  
Dividends per share (Unadj.) Rs097.37-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs382.81,977.9-  
Shares outstanding (eoy) m3.57848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.01.6 61.2%   
Avg P/E ratio x7.126.1 27.2%  
P/CF ratio (eoy) x6.211.4 54.5%  
Price / Book Value ratio x0.71.5 48.0%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m9622,458,242 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m1020-   
Avg. sales/employee Rs ThNM33,595.3-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,098.7-  
INCOME DATA
Net Sales Rs m9661,509,940 0.1%  
Other income Rs m380-   
Total revenues Rs m1,0031,509,940 0.1%   
Gross profit Rs m161413,498 0.0%  
Depreciation Rs m20122,050 0.0%   
Interest Rs m329,658 0.0%   
Profit before tax Rs m176261,790 0.1%   
Minority Interest Rs m01,189 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-171,851 0.0%   
Tax Rs m41-3,196 -1.3%   
Profit after tax Rs m13694,325 0.1%  
Gross profit margin %16.727.4 60.9%  
Effective tax rate %23.0-1.2 -1,887.1%   
Net profit margin %14.06.2 224.7%  
BALANCE SHEET DATA
Current assets Rs m1,1081,019,808 0.1%   
Current liabilities Rs m278889,358 0.0%   
Net working cap to sales %86.08.6 995.6%  
Current ratio x4.01.1 347.9%  
Inventory Days Days13591 148.9%  
Debtors Days Days1,48096 1,543.2%  
Net fixed assets Rs m567493,180 0.1%   
Share capital Rs m363,717 1.0%   
"Free" reserves Rs m1,3310-   
Net worth Rs m1,3661,677,256 0.1%   
Long term debt Rs m0772,066 0.0%   
Total assets Rs m1,6753,450,696 0.0%  
Interest coverage x63.29.8 643.5%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.4 131.7%   
Return on assets %8.33.6 229.9%  
Return on equity %9.95.6 176.4%  
Return on capital %13.14.9 265.6%  
Exports to sales %72.30-   
Imports to sales %2.00-   
Net fx Rs m6680-   
CASH FLOW
From Operations Rs m11240,606 0.0%  
From Investments Rs m-2-85,257 0.0%  
From Financial Activity Rs m3-288,623 -0.0%  
Net Cashflow Rs m12-133,274 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.33 Rs / USD

Compare CORAL LAB. With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare CORAL LAB. With: GANGA PHARMACEUTICALS  BIOFIL CHEMICALS  WOCKHARDT  CAPLIN POINT  JENBURKT PH.  



Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views On News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts... (Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks (Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

CORAL LAB. SHARE PRICE


Jan 21, 2022 (Close)

TRACK CORAL LAB.

  • Track your investment in CORAL LAB. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CORAL LAB.

CORAL LAB. - ALBERT DAVID COMPARISON

COMPARE CORAL LAB. WITH

MARKET STATS